or
Bookmark and Share
Long-acting antimicrobials
   
Document Number
US Patent 6479473
Issued Date
November 12, 2002
Link
Inventors
Map
Abstract
A method for producing an improved veterinary product is disclosed. The method comprises bringing a selected long-acting anticmicrobial formulation into intimate admixture with a predetermined amount of an anti-inflammatory agent and preparing the admixture for parenteral administration.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
4
Comments:
no comments yet
Published
November 12, 2002
Application Number
09/381,069
Filed
December 6, 1999
US Classification
514/152   424/405 424/406 514/352 514/974
Int'l Classification
A61K   31/65   (20060101)  
Examiner
USPTO Field of Search
424/405   424/422   424/406   514/974   514/152   514/352  
Related Patents
7404964 - Injectable compositions for the controlled delivery of pharmacologically active compound - Owned by Idexx Laboratories (Westbrook, ME)

The present invention provides compositions and methods for extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the pharmacologically active compound with a lipophilic counterion and a pharmaceutically acceptable water soluble solvent combined together to form an injectable composition. The lipophilic counterion may be a saturated or unsaturated C.sub.8-C.sub.22 fatty acid, and preferably may be a saturated or unsaturated C.sub.10-C.sub.18 fatty acid. When injected into a mammal, at least a portion of the composition precipitates and releases the active compound over time. Thus, the composition forms a slowly releasing drug depot of the active compound in the mammal. Therefore, the present invention enables one to provide a controlled dose administration of the active compound for a periods of up to 15 days or even longer. Many compounds can be administered according to the present invention including, but not limited to, tilmicosin, oxytetracycline, metoprolol, fluoxetine, roxithromycin, and turbinafine.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us